Zealand Pharma A/S

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DK0060257814
DKK
288.00
0.1 (0.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Zealand Pharma A/S Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
7,001.00
-1,083.00
-708.00
-972.00
-758.00
-839.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
87.00
122.00
52.00
-57.00
-196.00
54.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
6,531.00
-930.00
-425.00
-942.00
-1,211.00
-688.00
Cash Flow from Investing Activities
-2,248.00
-7,332.00
-1,094.00
281.00
-18.00
-196.00
Cash Flow from Financing Activities
-378.00
8,288.00
907.00
587.00
1,332.00
760.00
Net Cash Inflow / Outflow
3,850.00
30.00
-619.00
-59.00
168.00
-120.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-54.00
6.00
-7.00
13.00
66.00
3.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in DKK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Zealand Pharma A/S
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(DKK)
Change(%)
Profit Before Tax
7001.065
4487
2,514.00
56.03%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
87.726
-856
943.00
110.25%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
6531.933
4898
1,633.00
33.36%
Cash Flow from Investing Activities
-2248.506
-611
-1,637.00
-268.00%
Cash Flow from Financing Activities
-378.182
-5479
5,101.00
93.10%
Net Cash Inflow / Outflow
3850.508
-1231
5,081.00
412.80%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-54.737
-39
-15.00
-40.35%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 801.74% vs -118.67% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
6,531.93
-930.82
801.74%